Advertisement
Australia markets close in 1 hour 57 minutes
  • ALL ORDS

    8,115.50
    -16.60 (-0.20%)
     
  • ASX 200

    7,844.80
    -18.90 (-0.24%)
     
  • AUD/USD

    0.6656
    -0.0015 (-0.22%)
     
  • OIL

    79.34
    -0.46 (-0.58%)
     
  • GOLD

    2,417.70
    -20.80 (-0.85%)
     
  • Bitcoin AUD

    106,836.83
    +6,676.05 (+6.67%)
     
  • CMC Crypto 200

    1,534.12
    +179.70 (+13.27%)
     
  • AUD/EUR

    0.6129
    -0.0008 (-0.14%)
     
  • AUD/NZD

    1.0916
    -0.0002 (-0.02%)
     
  • NZX 50

    11,683.02
    -52.69 (-0.45%)
     
  • NASDAQ

    18,674.19
    +127.96 (+0.69%)
     
  • FTSE

    8,424.20
    +3.94 (+0.05%)
     
  • Dow Jones

    39,806.77
    -196.82 (-0.49%)
     
  • DAX

    18,768.96
    +64.54 (+0.35%)
     
  • Hang Seng

    19,234.33
    -401.89 (-2.05%)
     
  • NIKKEI 225

    39,099.79
    +30.11 (+0.08%)
     

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.